Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway

Abstract Introduction Prostate-specific antigen (PSA) is a reliable biomarker for identification of prostate cancer, although a biopsy is still the gold standard for detecting prostate cancer. Similar to higher PIRADS lesions on MRI, the maximal standard uptake value (SUV max) on PSMA PET is linked...

Full description

Bibliographic Details
Main Authors: Aditya Prakash Sharma, Rajender Kumar, Rohit Chauhan, Shiraz Akif Ziauddin, Shanky Singh, Harmandeep Singh, Sudheer Kumar Devana, Ujjwal Gorsi, Girdhar Singh Bora, Ravimohan S. Mavuduru, Santosh Kumar, Uttam K. Mete, Bhagwant Rai Mittal
Format: Article
Language:English
Published: SpringerOpen 2023-11-01
Series:European Journal of Hybrid Imaging
Subjects:
Online Access:https://doi.org/10.1186/s41824-023-00182-5
_version_ 1797630456289558528
author Aditya Prakash Sharma
Rajender Kumar
Rohit Chauhan
Shiraz Akif Ziauddin
Shanky Singh
Harmandeep Singh
Sudheer Kumar Devana
Ujjwal Gorsi
Girdhar Singh Bora
Ravimohan S. Mavuduru
Santosh Kumar
Uttam K. Mete
Bhagwant Rai Mittal
author_facet Aditya Prakash Sharma
Rajender Kumar
Rohit Chauhan
Shiraz Akif Ziauddin
Shanky Singh
Harmandeep Singh
Sudheer Kumar Devana
Ujjwal Gorsi
Girdhar Singh Bora
Ravimohan S. Mavuduru
Santosh Kumar
Uttam K. Mete
Bhagwant Rai Mittal
author_sort Aditya Prakash Sharma
collection DOAJ
description Abstract Introduction Prostate-specific antigen (PSA) is a reliable biomarker for identification of prostate cancer, although a biopsy is still the gold standard for detecting prostate cancer. Similar to higher PIRADS lesions on MRI, the maximal standard uptake value (SUV max) on PSMA PET is linked to a higher likelihood of prostate cancer. Can an mpMRI in conjunction with PSMA PET Scan accurately predict prostate cancer and further trigger omission of biopsy similar to other solid organ urological malignancies? Methods Ga-68 PSMA PET and mpMRI were performed for each patient who was a part of this retrospective study. The PET-positive lesion's maximum standardized uptake value (SUVmax) was recorded. Prostate biopsies were performed on patients who had PSMA PET avid lesions and a PIRADS score of 4 or 5. Robot-assisted radical prostatectomy (RARP) was afterward performed on patients who had cancer on their prostate biopsy. The prostatectomy specimen's histopathological information was recorded. Cutoff values and correlations between the variables were determined using the ROC curves and Pearson's correlation test. Result On the basis of suspicious DRE findings or elevated PSA, 70 men underwent mpMRI and PET scans. PIRADS 4 patients had a median (IQR) SUVmax of 8.75 (11.95); whereas, PIRADS 5 patients had an SUVmax of 24.5 (22). The mean SUVmax for patients whose biopsies revealed no cancer was 6.25 ± 1.41. With an AUC of 0.876 on the ROC curve, it was found that there was a significant positive correlation between the results of the mpMRI and PET scans and those of the histopathological investigation. A SUVmax ≥ 8.25 on PSMA PET for a PIRADS 4/5 lesion on mpMRI will aid in correctly predicting malignancy, with a sensitivity of 82.8% and specificity of 100%. Conclusion The findings of this study were positive and indicated that patients with a high suspicion of prostate cancer on mpMRI and PSMA PET (PIRADS ≥ 4 and SUVmax ≥ 8.25). This study substantiates the fact that a combination of mpMRI and PSMA PET can accurately predict localized prostate cancer.
first_indexed 2024-03-11T11:08:26Z
format Article
id doaj.art-65ddf68ab8b34c549df54091a72442c7
institution Directory Open Access Journal
issn 2510-3636
language English
last_indexed 2024-03-11T11:08:26Z
publishDate 2023-11-01
publisher SpringerOpen
record_format Article
series European Journal of Hybrid Imaging
spelling doaj.art-65ddf68ab8b34c549df54091a72442c72023-11-12T12:04:23ZengSpringerOpenEuropean Journal of Hybrid Imaging2510-36362023-11-017111110.1186/s41824-023-00182-5Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathwayAditya Prakash Sharma0Rajender Kumar1Rohit Chauhan2Shiraz Akif Ziauddin3Shanky Singh4Harmandeep Singh5Sudheer Kumar Devana6Ujjwal Gorsi7Girdhar Singh Bora8Ravimohan S. Mavuduru9Santosh Kumar10Uttam K. Mete11Bhagwant Rai Mittal12Department of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Nuclear Medicine, PGIMERDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Nuclear Medicine, PGIMERDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Radiodiagnosis, PGIMERDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Urology, Advance Urology Centre, PGIMER, Nehru HospitalDepartment of Nuclear Medicine, PGIMERAbstract Introduction Prostate-specific antigen (PSA) is a reliable biomarker for identification of prostate cancer, although a biopsy is still the gold standard for detecting prostate cancer. Similar to higher PIRADS lesions on MRI, the maximal standard uptake value (SUV max) on PSMA PET is linked to a higher likelihood of prostate cancer. Can an mpMRI in conjunction with PSMA PET Scan accurately predict prostate cancer and further trigger omission of biopsy similar to other solid organ urological malignancies? Methods Ga-68 PSMA PET and mpMRI were performed for each patient who was a part of this retrospective study. The PET-positive lesion's maximum standardized uptake value (SUVmax) was recorded. Prostate biopsies were performed on patients who had PSMA PET avid lesions and a PIRADS score of 4 or 5. Robot-assisted radical prostatectomy (RARP) was afterward performed on patients who had cancer on their prostate biopsy. The prostatectomy specimen's histopathological information was recorded. Cutoff values and correlations between the variables were determined using the ROC curves and Pearson's correlation test. Result On the basis of suspicious DRE findings or elevated PSA, 70 men underwent mpMRI and PET scans. PIRADS 4 patients had a median (IQR) SUVmax of 8.75 (11.95); whereas, PIRADS 5 patients had an SUVmax of 24.5 (22). The mean SUVmax for patients whose biopsies revealed no cancer was 6.25 ± 1.41. With an AUC of 0.876 on the ROC curve, it was found that there was a significant positive correlation between the results of the mpMRI and PET scans and those of the histopathological investigation. A SUVmax ≥ 8.25 on PSMA PET for a PIRADS 4/5 lesion on mpMRI will aid in correctly predicting malignancy, with a sensitivity of 82.8% and specificity of 100%. Conclusion The findings of this study were positive and indicated that patients with a high suspicion of prostate cancer on mpMRI and PSMA PET (PIRADS ≥ 4 and SUVmax ≥ 8.25). This study substantiates the fact that a combination of mpMRI and PSMA PET can accurately predict localized prostate cancer.https://doi.org/10.1186/s41824-023-00182-5mpMRIPSMA PETProstate cancerSUVmax
spellingShingle Aditya Prakash Sharma
Rajender Kumar
Rohit Chauhan
Shiraz Akif Ziauddin
Shanky Singh
Harmandeep Singh
Sudheer Kumar Devana
Ujjwal Gorsi
Girdhar Singh Bora
Ravimohan S. Mavuduru
Santosh Kumar
Uttam K. Mete
Bhagwant Rai Mittal
Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway
European Journal of Hybrid Imaging
mpMRI
PSMA PET
Prostate cancer
SUVmax
title Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway
title_full Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway
title_fullStr Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway
title_full_unstemmed Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway
title_short Accuracy of combined multi-parametric MRI and PSMA PET-CT in diagnosing localized prostate cancer: newer horizons for a biopsy-free pathway
title_sort accuracy of combined multi parametric mri and psma pet ct in diagnosing localized prostate cancer newer horizons for a biopsy free pathway
topic mpMRI
PSMA PET
Prostate cancer
SUVmax
url https://doi.org/10.1186/s41824-023-00182-5
work_keys_str_mv AT adityaprakashsharma accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT rajenderkumar accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT rohitchauhan accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT shirazakifziauddin accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT shankysingh accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT harmandeepsingh accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT sudheerkumardevana accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT ujjwalgorsi accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT girdharsinghbora accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT ravimohansmavuduru accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT santoshkumar accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT uttamkmete accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway
AT bhagwantraimittal accuracyofcombinedmultiparametricmriandpsmapetctindiagnosinglocalizedprostatecancernewerhorizonsforabiopsyfreepathway